A novel network pharmacology strategy to decode mechanism of Wuling Powder in treating liver cirrhosis.

"Disclosure The patients involved in the database have received ethical approval. Users are free to download the relevant data for research and publish relevant articles. Our research is based on open-source data, so there are no ethical issues or other conflicts of interest. Declarations Ethics approval and consent to participateNot applicable. Consent for publicationWritten informed consent for publication was obtained from all participants. Competing interestAll authors have declared that no conflict of interest exist. Competing interest All authors have declared that no conflict of interest exist."

"Funding This study was supported by the Startup Fund from the Southern Medical University (grant no. G820282016), Natural Science Foundation Council of China (grant nos. 31501080 and 32070676), Natural Science Foundation of Guangdong Province (grant no. 2021A1515010737 and 2023A1515012902), Hong Kong Baptist University Strategic Development Fund (grant no. SDF13-1209-P01, SDF15-0324-P02(b), SDF19-0402-P02), and Hong Kong Baptist University Interdisciplinary Research Matching Scheme (Grant No. RC/IRCs/17–18/04), and 2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund (Guangdong-Hong Kong-Macau Joint Lab, grant No. 2020B1212030006)."